White label ELPA - ClinicalTrials.eu

Study on Ravulizumab for Patients with Thrombotic Microangiopathy After Stem Cell Transplant

Not recruiting

3 1 1
Investigated diseases:
- Thrombotic microangiopathy
Investigated drugs:
- Ravulizumab
+3
Study of Empagliflozin for Patients with Autosomal Dominant Polycystic Kidney Disease

Not recruiting

3 1 1
Investigated diseases:
- Congenital cystic kidney disease
Investigated drugs:
- Empagliflozin
Study on the Effects of Gemlapodect for Adults and Adolescents with Tourette Syndrome

Not recruiting

2 1
Investigated drugs:
- Gemlapodect
Study on Cabozantinib for Patients with Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Thyroid cancer
Investigated drugs:
- Cabozantinib
Study on Prednisolone Transfer into Breast Milk and Infant Plasma for Mothers with Rheumatoid Arthritis and Other Inflammatory Conditions

Not recruiting

3 1 1 1
Investigated drugs:
- Betamethasone Sodium Phosphate
Study on the Effectiveness and Safety of allo-APZ2-CVU for Healing Chronic Venous Ulcers in Patients with Therapy-Resistant Wounds

Not recruiting

2 1
Investigated diseases:
- Skin ulcer
Investigated drugs:
- Allogeneic Skin-Derived Abcb5-Positive Dermal Mesenchymal Stromal Cells
Study of JNJ-68284528 for Treating Multiple Myeloma in Patients Using Ciltacabtagene Autoleucel and Drug Combination

Not recruiting

2 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
Study on the Effects and Safety of Emicizumab for Infants with Hemophilia A (Ages Birth to 12 Months)

Not recruiting

3 1 1 1
Investigated diseases:
- Haemophilia A without inhibitors
Investigated drugs:
- Emicizumab
Study on the Effects and Safety of INZ-701 for Children with ENPP1 Deficiency

Not recruiting

3 1 1
Investigated diseases:
- Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency
Investigated drugs:
- Recombinant Human Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Fused To The Fc Fragment Of Igg1
Study on Amantadine Hemisulfate for Patients with Unresponsive Wakefulness Syndrome in Intensive and Intermediate Care Units

Not recruiting

2 1 1 1
Investigated drugs:
- Amantadine Hemisulfate

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies